Please login to the form below

Not currently logged in
Email:
Password:

Silence appoints chief medical officer

Expands role of chief medical adviser Dr Michael Khan

Silence Therapeutics, Michael KhanUK biotech Silence Therapeutics has appointed Dr Michael Khan as its chief medical officer, four months after he joined the company as chief medical adviser.

In his new role Dr Khan, who is an associate professor of medicine at the University of Warwick, will oversee the company's 2013 programme of phase II clinical trials.

These studies involve Silence's investigational portfolio of RNA interference (RNAi) therapeutics, which aim to treat conditions by selectively turning off genes expressed in an individual with a certain disease.

Silence has several of these therapies in development across several indications, and is involved in several partnerships with companies including AstraZeneca.

Dr Khan said: “These are very exciting times for Silence Therapeutics, with one oncology drug advancing to phase II. Moreover, with a range of new indications in the pipeline, I am really happy to be a part of this dynamic new enterprise.”

Dr Khan's work has covered cancer and diabetes, and he has written several books on the subjects. He also teaches postgraduates and undergraduates in medicine and biological sciences in these areas.

In addition, Dr Khan is a fellow of the Royal College of Physicians of London and a member of the Association of Physicians, HEART-UK and Diabetes UK.

3rd January 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...

Infographics